Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.

Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.

Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to paediatric treatment regimens, the treatment of the elderly and non-human animals.

Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.

Abstract: The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.

Abstract: We disclose growth hormone fusion proteins that have increased in vivo stability and activity; nucleic acid molecules encoding said proteins and methods of treatment of growth hormone related diseases that would benefit from growth hormone agonists or antagonists.

Abstract: We disclose growth hormone fusion proteins that have increased in vivo stability and activity; nucleic acid molecules encoding said proteins and methods of treatment of growth hormone related diseases that would benefit from growth hormone agonists or antagonists.

Abstract: Systems and methods for continuous automatic adjustment of a control set point of an air-fuel ratio controller of a rich burn engine so as to maintain emissions within a desired range. In an embodiment, a NOx sensor is placed in the exhaust outlet from an exhaust catalyst and the NOx exhaust sensor output is continuously monitored while adjusting the control set point between rich and lean in order to minimize the output from the NOx sensor. Corrections may be continuously made to the set point during operation of the engine to compensate for changes in environmental conditions, engine loads, and other factors.

Abstract: The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.

Abstract: We describe lipid based pharmaceutical compositions adapted for oral delivery and optionally delivery in accordance with a circadian rhythm.

Abstract: In one exemplary embodiment, a computer-implemented method includes the step of providing an image to a user. The image is provided with a computer display. An eye-tracking data is obtained from the user when the user views the image. The eye-tracking data is obtained with an eye-tracking system. A user attribute is determined based on the eye-tracking data. The user is enabled to access a digital resource when the user attribute is associated with a permission to access the digital resource. The user attribute can be a personhood state. The digital resource can be a web page document. An instruction can be provided to the user regarding a pattern of viewing the image. The pattern of viewing the image can include instructing the user to gaze on a specified sequence of image elements.

Abstract: We describe lipid based pharmaceutical compositions adapted for oral delivery and optionally delivery in accordance with a circadian rhythm.

Abstract: In one exemplary embodiment, a computer-implemented method includes the step of providing an image to a user. The image is provided with a computer display, An eye-tracking data is obtained from the user when the user views the image. The eye-tracking data is obtained with an eye-tracking system. A user attribute is determined based on the eye-tracking data. The user is enabled to access a digital resource when the user attribute is associated with a permission to access the digital resource. The user attribute can be a personhood state. The digital resource can be a web page document. An instruction can be provided to the user regarding a pattern of viewing the image. The pattern of viewing the image can include instructing the user to gaze on a specified sequence of image elements.

Abstract: In one exemplary embodiment, a method includes the step of receiving eye tracking information associated with eye movement of a user of a computing system from an eye tracking system coupled to a computing system The computing system is in a messaging mode of operation and is displaying an element of a message. Based on the eye tracking information, is determined that a path associated with the eye movement associates an external object with a portion of the message. Information about the external object is automatically associated with the portion of the message.

Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.

Abstract: In one aspect, a method includes generating, with at least one processor of a smart device, a microblog post. The microblog post is automatically generated by the smart device. The smart device includes a sensor. The microblog post includes a message component. A meaning of the message component is determined. A step includes automatically measuring an environment attribute of the smart device with the sensor. The sensor data is related to a meaning of the message component. A context-data tag is automatically generated. The context-data tag includes an alphanumeric textual description of the sensor data. The message component and the context data tag are associated in the microblog post.

Abstract: We disclose growth hormone fusion proteins that have increased in vivo stability and activity; nucleic acid molecules encoding said proteins and methods of treatment of growth hormone related diseases that would benefit from growth hormone agonists or antagonists.

Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to paediatric treatment regimens, the treatment of the elderly and non-human animals.

Abstract: An embankment system comprises a source of pressurized sand/concrete slurry and a delivery conduit in fluid communication with the pressurized sand/concrete slurry source. The embankment system further comprises an elongate nozzle having an inlet and an outlet, with the inlet operatively associated with a distal end of the delivery conduit. A tube formed of a sheet material having an open end and a closed end is operatively associated with the nozzle outlet to receive the pressurized sand/concrete slurry through the open end, such that the tube is continuously filled with the pressurized sand/concrete slurry between the closed end and the open end.